Advancements in Parkinson's Treatment through Stem Cell Therapy

This chapter explores a clinical trial utilizing hES cell-derived dopaminergic neurons for treating Parkinson's disease, detailing participant selection and safety measures. It highlights the positive outcomes observed in motor performance and the absence of severe adverse effects, emphasizing the importance of monitoring long-term effects. Additionally, future research directions are discussed, including an upcoming phase three trial aimed at further improving treatment strategies.